IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
-12.71%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$214M
AUM Growth
+$214M
(-13%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
45.58%
Holding
87
New
19
Increased
19
Reduced
16
Closed
12
Top Buys
| 1 |
Elevance Health
ELV
|
$7M |
| 2 |
McKesson
MCK
|
$5.55M |
| 3 |
AET
Aetna Inc
AET
|
$5.47M |
| 4 |
Bausch Health
BHC
|
$5.35M |
| 5 |
Biogen
BIIB
|
$4.38M |
Top Sells
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$8.67M |
| 2 |
STJ
St Jude Medical
STJ
|
$7.31M |
| 3 |
CELG
Celgene Corp
CELG
|
$6.49M |
| 4 |
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
|
$4.15M |
| 5 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$3.02M |
Sector Composition
| 1 | Healthcare | 88.11% |
| 2 | Financials | 2.56% |
| 3 | Consumer Staples | 1.48% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Elevance Health
ELV
$71.8B
| $14M | 5.51% | 100,000 +50,000 | +100% | +$7M |
|
|
2
Bausch Health
BHC
$2.74B
| $11.6M | 4.56% | 65,000 +30,000 | +86% | +$5.35M |
|
|
3
Ultragenyx Pharmaceutical
RARE
$2.89B
| $10.6M | 4.17% | 110,000 -90,000 | -45% | -$8.67M |
|
4
Gilead Sciences
GILD
$140B
| $9.82M | 3.86% | 100,000 | – | – |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $9.74M | 3.83% | 90,000 -60,000 | -40% | -$6.49M |
|
6
Pfizer
PFE
$141B
| $9.42M | 3.71% | 300,000 +100,000 | +50% | +$3.14M |
|
7
Amgen
AMGN
$155B
| $8.99M | 3.54% | 65,000 +5,000 | +8% | +$692K |
|
|
8
Biogen
BIIB
$19.4B
| $8.75M | 3.44% | 30,000 +15,000 | +100% | +$4.38M |
|
9
Edwards Lifesciences
EW
$47.8B
| $8.53M | 3.35% | 60,000 +25,000 | +71% | +$3.55M |
|
|
ESRX
10
DELISTED
Express Scripts Holding Company
ESRX
| $6.07M | 2.39% | 75,000 -25,000 | -25% | -$2.02M |
|
11
Teva Pharmaceuticals
TEVA
$21.1B
| $5.65M | 2.22% | 100,000 +25,000 | +33% | +$1.41M |
|
|
12
McKesson
MCK
$85.4B
| $5.55M | 2.18% | +30,000 | New | +$5.55M |
|
|
AET
13
DELISTED
Aetna Inc
AET
| $5.47M | 2.15% | +50,000 | New | +$5.47M |
|
14
Cigna
CI
$80.3B
| $5.4M | 2.12% | 40,000 | – | – |
|
|
NVDQ
15
DELISTED
Novadaq Technologies Inc.
NVDQ
| $5.22M | 2.05% | 500,000 +100,000 | +25% | +$1.04M |
|
16
Medtronic
MDT
$119B
| $5.02M | 1.97% | 75,000 -25,000 | -25% | -$1.67M |
|
|
ENDP
17
DELISTED
Endo International plc
ENDP
| $4.85M | 1.91% | 70,000 +45,000 | +180% | +$3.12M |
|
18
Viatris
VTRS
$12.3B
| $4.43M | 1.74% | 110,000 +35,000 | +47% | +$1.41M |
|
|
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.96M | 1.56% | 200,000 | – | – |
|
|
GWPH
20
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.66M | 1.44% | 40,000 -5,000 | -11% | -$457K |
|
|
LJPC
21
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $3.47M | 1.37% | +125,000 | New | +$3.47M |
|
|
MDRX
22
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.22M | 1.27% | 260,000 +10,000 | +4% | +$124K |
|
|
WOOF
23
DELISTED
VCA Inc.
WOOF
| $3.16M | 1.24% | +60,000 | New | +$3.16M |
|
|
TRNX
24
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $3.06M | 1.2% | 150,000 | – | – |
|
|
MDVN
25
DELISTED
MEDIVATION, INC.
MDVN
| $2.98M | 1.17% | +70,000 | New | +$2.98M |
|